Tag Archives: Britain partners with Oxford firm to assess coronavirus vaccine T cell responses

LONDON: Britain on Thursday said it would partner with an Oxford-based firm to provide testing for the T cell response of coronavirus vaccine candidates to try to assess their immune responses. T cell immunity is thought to be essential to protection against infection from the SARS-COV-2 coronavirus, and could provide longer term immunity than antibodies. The UK Vaccine Taskforce has …

Read More »